Blair William & CO Assembly Biosciences, Inc. Transaction History

Blair William & CO

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$3.14 - $3.9 $50,240 - $62,400	-16,000 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$3.8 - $4.56 $1,900 - $2,280	-500 Reduced 3.03%	16,000 $62,000
Q1 2021 May 13, 2021	BUY	$4.33 - $6.63 $71,445 - $109,395	16,500 New	16,500 $76,000
Q4 2020 Feb 09, 2021	SELL	$4.87 - $17.29 $58,440 - $207,480	-12,000 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$15.08 - $27.04 $12,802 - $22,956	-849 Reduced 6.61%	12,000 $197,000
Q1 2020 May 11, 2020	SELL	$10.27 - $21.23 $363,948 - $752,348	-35,438 Reduced 73.39%	12,849 $191,000
Q4 2019 Feb 13, 2020	BUY	$8.36 - $23.81 $320,079 - $911,613	38,287 Added 382.87%	48,287 $988,000
Q3 2019 Nov 12, 2019	SELL	$9.83 - $14.82 $17,939 - $27,046	-1,825 Reduced 15.43%	10,000 $98,000
Q2 2019 Aug 13, 2019	BUY	$12.9 - $20.8 $12,900 - $20,800	1,000 Added 9.24%	11,825 $160,000
Q1 2019 May 14, 2019	BUY	$17.7 - $24.93 $29,859 - $42,056	1,687 Added 18.46%	10,825 $213,000
Q4 2018 Feb 14, 2019	SELL	$19.05 - $36.45 $10,477 - $20,047	-550 Reduced 5.68%	9,138 $207,000
Q3 2018 Nov 13, 2018	SELL	$34.41 - $44.23 $103,229 - $132,690	-3,000 Reduced 23.64%	9,688 $360,000
Q2 2018 Aug 13, 2018	SELL	$39.21 - $50.29 $8,822 - $11,315	-225 Reduced 1.74%	12,688 $497,000
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $250,742 - $385,794	6,013 Added 87.14%	12,913 $635,000
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $197,202 - $344,379	6,900	6,900 $312,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.